Showing results (181-190 of 405) with videos related to
Sort By:
Pageof 41
Journal of Neuroinflammation|May 30, 2023
miRNA 548a-3p as biomarker of NEDA-3 at 2 years in multiple sclerosis patients treated with fingolimodAlicia Gonzalez-Martinez, Rohit Patel, Brian C Healy, et al.The Journal of Clinical Investigation|October 3, 2003
Regulatory functions of CD8+CD28- T cells in an autoimmune disease modelNader Najafian, Tanuja Chitnis, Alan D Salama, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|February 4, 2017
Oral contraceptives and MS disease activity in a contemporary real-world cohortRiley Bove, Kelsey Rankin, Alicia S Chua, et al.Scientific Reports|April 8, 2025
Novel serum biomarker associations with 7 Tesla MRI-defined cortical lesions, leptomeningeal enhancement, and deep gray matter volume in early multiple sclerosisAndrei Miclea, Jonathan Zurawski, Brian C Healy, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2003
CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanismDoo Ryeon Chung, Dennis L Kasper, Ronald J Panzo, et al.Multiple Sclerosis and Related Disorders|May 16, 2022
Disease modifying therapy management of multiple sclerosis after stem cell therapies: A retrospective case seriesGiovanna S Manzano, Kathryn B Holroyd, Tamara Kaplan, et al.Neurology|May 3, 2019
Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSGEmmanuelle Waubant, Brenda Banwell, Evangeline Wassmer, et al.BMJ Neurology Open|March 21, 2022
Effect of fingolimod on health-related quality of life in paediatric patients with multiple sclerosis: results from the phase 3 PARADIGMS StudyLauren Krupp, Brenda Banwell, Tanuja Chitnis, et al.Neurology(R) Neuroimmunology & Neuroinflammation|September 6, 2023
A 28-Year-Old Woman With Left-Sided Weakness and Atypical MRI Lesions: From the National Multiple Sclerosis Society Case Conference ProceedingsAmy L Safadi, Benjamin Osborne, Tanuja Chitnis, et al.Journal of the Neurological Sciences|February 9, 2024
Predictors of relapsing disease course following index event in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)Negar Molazadeh, Philippe A Bilodeau, Rebecca Salky, et al.Pageof 41